Immune Response of a Heterologous mRNA-1273 Second-Dose Immunization after a First Dose of ChadOx1 against SARS-CoV-2: A Cross-Sectional Study

Heterologous vaccination regimens could contribute to broadening vaccination coverage. To date, there is little evidence on the effectiveness of a combination of adenoviral COVID-19 vaccines with a second dose of mRNA vaccines. This study aims to evaluate the antibody response to the SARS-CoV-2 spik...

Descripción completa

Detalles Bibliográficos
Autores principales: Albanesi, Beatrice, Godono, Alessandro, Comoretto, Rosanna Irene, Casabona, Elena, Curoso, Giuliano, Leone, Massimiliano Victor, Milanesio, Nicolò, Mirra, Ilenia, Montrucchio, Giulia, Pittaluga, Fabrizia, Cavallo, Rossana, Clari, Marco, Ciocan, Catalina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416710/
https://www.ncbi.nlm.nih.gov/pubmed/36016129
http://dx.doi.org/10.3390/vaccines10081241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416710/
https://www.ncbi.nlm.nih.gov/pubmed/36016129
http://dx.doi.org/10.3390/vaccines10081241

Ejemplares similares